Medacta Group (XSWX:MOVE) ROCE % : 7.33% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Medacta Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medacta Group's annualized ROCE % for the quarter that ended in Dec. 2023 was 7.33%.

Medacta Group ROCE % Historical Data

The historical data trend for Medacta Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medacta Group ROCE % Chart

Medacta Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

6.16

14.52

17.81

13.48

12.31

Medacta Group Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial									12.91	17.86	9.14	17.92	7.33

Medacta Group ROCE % Calculation

Medacta Group's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	61.824	/	( ( (576.81 - 87.892)	+	(656.259 - 140.915) )	/ 2 )
	=	61.824	/	( (488.918	+	515.344)	/ 2 )
	=	61.824	/	502.131
	=	12.31 %

Medacta Group's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	37.432	/	( ( (628.842 - 122.301)	+	(656.259 - 140.915) )	/ 2 )
	=	37.432	/	( ( 506.541	+	515.344 )	/ 2 )
	=	37.432	/	510.9425
	=	7.33 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Medacta Group (XSWX:MOVE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medacta Group ROCE % Related Terms

Thank you for viewing the detailed overview of Medacta Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medacta Group (XSWX:MOVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medacta Group SA (XSWX:MOVE) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

MOVEz:UK

Address

Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874

Website

https://www.medacta.com

Medacta Group SA is a Switzerland based company involved in developing, manufacturing and distributing orthopaedic and neurosurgical medical devices worldwide. The company offers solutions for Hip, Knee, Shoulder and Spine.